Surgical therapy of peri‐implantitis

Abstract Peri‐implantitis is caused by a bacterial challenge; therefore, anti‐infective treatment strategies should be employed to manage the disease. As nonsurgical approaches demonstrate limited efficacy in most cases of peri‐implantitis, surgical interventions are often required. Treatment outcomes improve following access flap surgery, with or without adjunctive resective and/or augmentation measures. Whereas nonaugmentative therapies (ie, access flap surgery and resective techniques) primarily aim to resolve inflammation and arrest further disease progression, augmentation approaches also seek to regenerate the bony defect and achieve reosseointegration. Currently, limited evidence supports the superiority of augmentative surgical techniques for peri‐implantitis treatment over nonaugmentation methods, and human histologic evidence for reosseointegration is sparse. For patients involved in regular postoperative maintenance programs, success of peri‐implantitis surgical treatment based on various definitions of success was obtained in over half of the cases after 5‐7 years. Despite surgical treatment, cases of further disease progression that required retreatment or led to implant loss were reported.